Readily Diagnostics
Readily Diagnostics develops molecular tests that help clinicians identify infectious diseases near the patient without relying on a central laboratory.
~$970KGates Foundation grant
ParticipantGF
Gates Foundation
Activity from announced rounds
All recorded activity
- Rounds participated in
- 7
- Confirmed lead rounds
- 0 6 roles undisclosed
- New companies
- 7 First participation on record · 0 follow-on
- Funding in participating rounds
- $178.3M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
7 in all activityProFound Therapeutics
Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia
$35MStrategic
Role not disclosedLeyden Laboratories
Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections.
€40MSeries B
Role not disclosedKanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosedTen63 Therapeutics
Develops AI-driven drug discovery platform for first- and best-in-class therapeutics
$45MStrategic
Role not disclosedHeritable Agriculture
Develops AI-driven crop improvement solutions for climate-resilient crops
$5MGrant
Role not disclosedQure.ai
Develops AI-powered diagnostic solutions for early detection and care management of diseases
UndisclosedGrant
Role not disclosed